1006-major
78d22836-a442-7c0c-e053-2991aa0a62f3
34390-5
HUMAN OTC DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
Active ingredient (in each tablet) Dimenhydrinate 50 mg
Medication Information
Warnings and Precautions
Do not give to children under 2 years of age unless directed by a doctor
Description
Active ingredient (in each tablet) Dimenhydrinate 50 mg
Uses
for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness
Section 34088-5
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Section 42229-5
KEEP OUTER PACKAGE FOR COMPLETE PRODUCT INFORMATION
*This product is not manufactured or distributed by Medtech Products Inc., owner of the registered trademark Dramamine®.
Distributed by: MAJOR® PHARMACEUTICALS
Indianapolis, IN 46268
Questions or comments?
Call (800) 616-2471
www.majorpharmaceuticals.com
Section 50565-1
Keep out of reach of children.
Section 50567-7
When using this product
■ marked drowsiness may occur
■ avoid alcoholic drinks
■ alcohol, sedatives, and tranquilizers may increase drowsiness
■ use caution when driving a motor vehicle or operating machinery
Section 50568-5
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
Section 50569-3
Ask a doctor before use if you have
■ glaucoma
■ a breathing problem such as emphysema or chronic bronchitis
■ trouble urinating due to an enlarged prostate gland
Section 51727-6
croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose
Section 51945-4
MAJOR ®
NDC 0904-6772-12
Compare to the Active Ingredient in DRAMAMINE ® Original Formula*
Driminate TM
Dimenhydrinate USP, Antiemetic
For Nausea, Dizziness and Vomiting from Motion Sickness
12 Tablets 50mg Each
Use as Directed
Section 53414-9
If pregnant or breast-feeding, ask a health professional before use.
.
Section 55105-1
Purpose
Antiemetic
Directions
■ to prevent motion sickness, the rst dose should be taken one-half to one hour before starting activity
■ adults and children 12 years of age and over: 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours, or as directed by a doctor
■ children 6 to under 12 years of age: 1/2 to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours, or as directed by a doctor
■ children 2 to under 6 years of age: 1/2 tablet every 6-8 hours; not to exceed 1 1/2 tablets in 24 hours, or as directed by a doctor
Drug Facts
Active ingredient (in each tablet)
Dimenhydrinate 50 mg
Other Information
■ each tablet contains: calcium 30 mg
■ store in a dry place at 15° – 30°C (59° – 86°F)
■ protect from moisture
■ see end -ap for expiration date and lot number
■ TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN
Questions Or Comments?
1-800-231-4670
Structured Label Content
Uses
for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness
Warnings and Precautions (34071-1)
Do not give to children under 2 years of age unless directed by a doctor
Section 34088-5 (34088-5)
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Section 42229-5 (42229-5)
KEEP OUTER PACKAGE FOR COMPLETE PRODUCT INFORMATION
*This product is not manufactured or distributed by Medtech Products Inc., owner of the registered trademark Dramamine®.
Distributed by: MAJOR® PHARMACEUTICALS
Indianapolis, IN 46268
Questions or comments?
Call (800) 616-2471
www.majorpharmaceuticals.com
Section 50565-1 (50565-1)
Keep out of reach of children.
Section 50567-7 (50567-7)
When using this product
■ marked drowsiness may occur
■ avoid alcoholic drinks
■ alcohol, sedatives, and tranquilizers may increase drowsiness
■ use caution when driving a motor vehicle or operating machinery
Section 50568-5 (50568-5)
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
Section 50569-3 (50569-3)
Ask a doctor before use if you have
■ glaucoma
■ a breathing problem such as emphysema or chronic bronchitis
■ trouble urinating due to an enlarged prostate gland
Section 51727-6 (51727-6)
croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose
Section 51945-4 (51945-4)
MAJOR ®
NDC 0904-6772-12
Compare to the Active Ingredient in DRAMAMINE ® Original Formula*
Driminate TM
Dimenhydrinate USP, Antiemetic
For Nausea, Dizziness and Vomiting from Motion Sickness
12 Tablets 50mg Each
Use as Directed
Section 53414-9 (53414-9)
If pregnant or breast-feeding, ask a health professional before use.
.
Section 55105-1 (55105-1)
Purpose
Antiemetic
Directions
■ to prevent motion sickness, the rst dose should be taken one-half to one hour before starting activity
■ adults and children 12 years of age and over: 1 to 2 tablets every 4-6 hours; not to exceed 8 tablets in 24 hours, or as directed by a doctor
■ children 6 to under 12 years of age: 1/2 to 1 tablet every 6-8 hours; not to exceed 3 tablets in 24 hours, or as directed by a doctor
■ children 2 to under 6 years of age: 1/2 tablet every 6-8 hours; not to exceed 1 1/2 tablets in 24 hours, or as directed by a doctor
Drug Facts
Active ingredient (in each tablet)
Dimenhydrinate 50 mg
Other Information (Other information)
■ each tablet contains: calcium 30 mg
■ store in a dry place at 15° – 30°C (59° – 86°F)
■ protect from moisture
■ see end -ap for expiration date and lot number
■ TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN
Questions Or Comments? (Questions or comments?)
1-800-231-4670
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T12:06:53.129339 · Updated: 2026-03-14T23:09:55.704959